00:00 / 00:00
Spinocerebellar ataxia (NORD)
0 / 5 complete
Spinocerebellar ataxia or SCA refers to a group of rare genetically inherited conditions, caused by mutations in several types of SCA genes.
Once there, the cerebellum uses this information to coordinate and plan movement as well as maintain balance.
In fact, many different gene mutations have been identified, each of which is known to cause different types of spinocerebellar ataxia.
The types are described using "SCA" followed by a number, according to their order of identification, so there’s SCA1 through SCA48, with SCA3 being the most common type.
However, in about 40% to 25% of the cases, the causative genes are still unknown.
Now, most of these gene mutations are inherited in an autosomal dominant pattern, meaning that one copy of an altered SCA gene is enough to cause the disease.
Affected individuals have a 50% chance of passing on the altered gene to their child, causing that child to have the disease.
In some cases, the involved gene contains a triplet repeat, where the nucleotides C, A, and G are repeated multiple times in a row.
And since CAG codes for the amino acid glutamine, the encoded protein will have multiple extra glutamines in a row.
The specific way in which extra glutamines causes the disease’s symptoms isn’t fully understood, but the abnormal protein seems to aggregate within the neurons of the cerebellum and spinal cord, causing them to die.
The expanded CAG repeats also affect DNA replication itself.
Spinocerebellar ataxia or SCA is a progressive, genetic, and often fatal neurodegenerative disorder with multiple types, caused by SCA gene mutations. These mutations result in degenerative changes in the cerebellum and the spinal cord, which causes progressive problems with coordination and balance, known as ataxia.
Symptoms of SCA vary depending on the subtype, but common ones include gait abnormalities, limb ataxia, dysarthria, nystagmus, and progressive difficulty with balance and coordination. Some subtypes of SCA can also cause vision problems, hearing loss, and cognitive impairment.
Diagnosis includes neuroimaging and genetic sequencing, and treatment options are mainly focused on managing symptoms and improving quality of life since there is no definitive cure. Physical therapy can help to maintain mobility and prevent falls, while speech therapy can help to improve communication abilities. In some cases, medications can be used to manage symptoms such as tremors or spasticity.
Copyright © 2023 Elsevier, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
Cookies are used by this site.
USMLE® is a joint program of the Federation of State Medical Boards (FSMB) and the National Board of Medical Examiners (NBME). COMLEX-USA® is a registered trademark of The National Board of Osteopathic Medical Examiners, Inc. NCLEX-RN® is a registered trademark of the National Council of State Boards of Nursing, Inc. Test names and other trademarks are the property of the respective trademark holders. None of the trademark holders are endorsed by nor affiliated with Osmosis or this website.